Joshua Welch, PhD, is awarded a new Chan Zuckerberg Initiative grant

Joshua Welch, Ph.D., an associate professor in the Department of Computational Medicine and Bioinformatics (DCMB) was awarded a Chan Zuckerberg Initiative (CZI) grant for his project titled: “Atlas-scale Hierarchical Identification of Cell Types and Functions.”

With this new funding, the Welch lab will develop an AI approach for identifying the type of a cell from its gene expression. While many previous approaches for this problem exist, theirs is unique in its ability to use both general and specific cell type annotations to calibrate its predictions. Another unique aspect of this project is in predicting the functions that cells can perform based on gene expression. The ability to predict these properties would save much time and standardize the vocabulary scientists use when analyzing single cell RNA sequencing (scRNA) data.

“We are excited to work toward better cell type classification algorithms, and we're grateful for both the funding and the infrastructure that CZI has developed that makes this project possible.”—Joshua Welch, Ph.D.

This project depends on the availability of many high-quality scRNA datasets with manually curated labels. The Welch team plans to use CZI's CZ CELLxGENE Discover Census dataset, which is the largest single collection of scRNA data in which every cell is labeled with a cell ontology term. 

This project will use the latest neural network approaches to develop an AI approach that can label cells. The key challenge for this project is to address the laborious, subjective, and error-prone nature of manually labeling cell types. The latest AI models provide a promising solution to this challenge.

Welch and his Ph.D. candidate Jialin Liu already received a grant from CZI in 2023 for developing two novel computational tools that detect signaling among single cells from spatial transcriptomic data. Read more.

Congratulations, Dr. Welch!

In This Story
Joshua Welch Joshua Welch, PhD

Associate Professor

Featured News & Stories Cover of M&I annual highlights -
Department News
2023–2024 Highlights from the Department of Microbiology and Immunology: "New Beginnings"
2023–2024 highlights from the Department of Microbiology and Immunology
frozen dial with ice on it with red dial
Health Lab
Enzyme identified as new therapeutic target for “cold” tumors
A study identifies an enzyme as a new therapeutic target for “cold” tumors.
three friends standing outside rogel cancer center building with big white ribbons
Health Lab
A lung cancer survivor shaping lung cancer advocacy
One woman's unexpected lung cancer diagnosis leads her to help many who aren't aware they're at risk of the disease.
Dr traynor working in lab
Department News
Drs. John Traynor and Jessica Anand have identified a molecule that appears to restore normal breathing in mice following a large dose of fentanyl
Scientists have identified a molecule that appears to restore normal breathing in mice following a large dose of fentanyl.
U-M Block M
Department News
Faculty Search in Pharmacology
The Department of Pharmacology and the Michigan Neuroscience Institute are seeking a tenure-track faculty, open rank, with interest in substance use disorders and expertise in behavioral pharmacology and/or biopsychology.
On left, a young boy in a wheelchair has his doctor standing to his left and his parent is standing to his right in a show of support. On the right side of the image, the boy is now an adult and is wondering about the cost of his care and if his questions will be answered.
Health Lab
Changing the definition of cerebral palsy
Cerebral palsy is defined as a childhood disorder, which fails to recognize adults living with the condition and the lack of care they receive once they age out of pediatric clinics.